[Code of Federal Regulations]

[Title 32, Volume 1]

[Revised as of July 1, 2006]

From the U.S. Government Printing Office via GPO Access

[CITE: 32CFR58.3]



[Page 376-377]

 

                       TITLE 32--NATIONAL DEFENSE

 

              CHAPTER I--OFFICE OF THE SECRETARY OF DEFENSE

 

PART 58_HUMAN IMMUNODEFICIENCY VIRUS (HIV-1)--Table of Contents

 

Sec.  58.3  Definitions.



    (a) Human Immunodeficiency Virus-1 (HIV-1). The virus most commonly 

associated with the Acquired Immune Deficiency Syndrome (AIDS) in the 

United States.

    (b) HIV-1 and/or AIDS Education Program. Any combination of 

information, education, and behavior-change strategies designed to 

facilitate behavioral alteration that will improve or protect health. 

Included are those activities intended to support or influence 

individuals in managing their own health through lifestyle decisions and 

self-care. Operationally, such programs include community, worksite, and 

clinical aspects using appropriate public health education 

methodologies.

    (c) Serologic Evidence of HIV-1 Infection. A reactive result given 

by a Food and Drug Administration (FDA)-approved enzyme-linked 

immunosorbent assay (ELISA) serologic test that is confirmed by a 

reactive and diagnostic immunoelectrophoresis test (Western blot (WB)) 

test on two separate samples.

    (d) Host Nation. A foreign nation to which DoD U.S. civilian 

employees are assigned to perform their official duties.

    (e) DoD Civilian Employees. Current and prospective DoD U.S. 

civilian employees, including appropriated and nonappropriated fund 

personnel. This does not include members of the family of DoD civilian 

employees, employees of, or applicants for, positions with contractors 

performing work for the Department of Defense, or their families.

    (f) Epidemiological Assessment. The process by which personal and 

confidential information on the possible



[[Page 377]]



modes of transmission of HIV-1 are obtained from an HIV-1 infected 

person. This information is used to determine if previous, present, or 

future contacts of the infected individual are at risk for infection 

with HIV-1 and to prevent further transmission of HIV-1.